Also trades as: KOPRAN.NS (NSE) · $vol 3M

₹274.75 ($2.85)

-7.50 (-2.66%)

BSE · Healthcare · Drug Manufacturers - General · Tech Score Buy · Power 63 · ₹13.7B mcap · 23M float · 0.283% daily turnover

Revenue

$6.8B +8.2% ▲

5Y CAGR: +7.2%

Gross Profit

$1.6B -29.0% ▼

5Y CAGR: -0.9%

Operating Income

$604M -63.3% ▼

5Y CAGR: -3.8%

Net Income

$257M -33.3% ▼

5Y CAGR: -16.0%

EPS (Diluted)

$5.33 -33.3% ▼

5Y CAGR: -17.8%

EBITDA

$623M -14.5% ▼

5Y CAGR: -9.0%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$4.7B	$5.5B	$6.1B	$6.3B	$6.8B
YoY Growth	-1.5%	+15.6%	+12.1%	+2.4%	+8.2%
Cost of Revenue	$2.8B	$3.6B	$4.1B	$4.0B	$5.2B
Gross Profit	$1.9B	$1.9B	$2.1B	$2.2B	$1.6B
Gross Margin	40.1%	34.0%	34.0%	35.7%	23.4%
R&D Expenses	$7M	$7M	$10M	$0	$0
SG&A Expenses	$171M	$185M	$199M	$605M	$993M
Operating Expenses	$376M	$431M	$372M	$605M	$993M
Operating Income	$768M	$445M	$657M	$1.6B	$604M
Operating Margin	16.2%	8.1%	10.7%	26.1%	8.9%
Interest Expense	$51M	$61M	$86M	$93M	$105M
Income Before Tax	$818M	$361M	$675M	$519M	$344M
Tax Expense	$207M	$88M	$166M	$134M	$86M
Net Income	$610M	$272M	$510M	$386M	$257M
Net Margin	12.9%	5.0%	8.3%	6.1%	3.8%
EPS (Diluted)	$13.77	$5.65	$10.57	$7.99	$5.33
EBITDA	$980M	$549M	$868M	$729M	$623M
Shares Outstanding	44M	48M	48M	48M	48M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$1.4B	$1.5B	$1.7B	$1.7B	$1.4B	$1.2B	$1.9B	$2.3B
Cost of Revenue	$859M	$977M	$1.1B	$1.2B	$854M	$760M	$1.5B	$1.7B
Gross Profit	$535M	$539M	$605M	$570M	$498M	$419M	$422M	$665M
Gross Margin	38.4%	35.6%	36.4%	33.1%	36.8%	35.5%	21.7%	28.4%
R&D Expenses	$0	$0	$0	$10M	$0	$0	$0	$0
SG&A Expenses	$133M	$0	$0	$173M	$0	$0	$264M	$304M
Operating Expenses	$392M	$430M	$416M	$173M	$399M	$432M	$264M	$304M
Operating Income	$143M	$109M	$189M	$132M	$99M	-$13M	$158M	$361M
Operating Margin	10.2%	7.2%	11.4%	7.7%	7.3%	-1.1%	8.1%	15.4%
Interest Expense	$22M	$22M	$22M	$28M	$25M	$21M	$27M	$32M
Income Before Tax	$147M	$96M	$139M	$137M	$99M	-$116M	$107M	$253M
Tax Expense	$36M	$23M	$35M	$40M	$24M	-$17M	$14M	$65M
Net Income	$111M	$74M	$104M	$97M	$74M	-$99M	$93M	$189M
Net Margin	8.0%	4.9%	6.3%	5.6%	5.5%	-8.4%	4.8%	8.1%
EPS (Diluted)	$2.30	$1.53	$2.15	$2.01	$1.54	$-2.06	$1.93	$3.91
EBITDA	$208M	$157M	$200M	$171M	$167M	-$53M	$178M	$330M
Shares Outstanding	48M	48M	48M	48M	48M	48M	48M	48M

KOPRAN.BO BSE